CL
UTHR icon

CIM LLC’s United Therapeutics UTHR Stock Holding History

CIM LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,546
Closed -$509K – 89
2016
Q4 		$509K Sell
3,546
-105
-3% -$13.4K 0.26% 41
2016
Q3 		$431K Sell
3,651
-37
-1% -$4.45K 0.2% 55
2016
Q2 		$391K Buy
3,688
+313
+9% +$34.9K 0.2% 53
2016
Q1 		$376K Buy
3,375
+70
+2% +$8.86K 0.19% 55
2015
Q4 		$518K Buy
3,305
+47
+1% +$6.84K 0.25% 33
2015
Q3 		$428K Sell
3,258
-65
-2% -$10.4K 0.22% 39
2015
Q2 		$578K Sell
3,323
-120
-3% -$21.6K 0.27% 32
2015
Q1 		$594K Sell
3,443
-582
-14% -$88.7K 0.28% 35
2014
Q4 		$521K Sell
4,025
-205
-5% -$26.4K 0.25% 35
2014
Q3 		$544K Buy
4,230
+80
+2% +$8.25K 0.27% 30
2014
Q2 		$367K Buy
4,150
+320
+8% +$30.8K 0.18% 55
2014
Q1 		$360K Sell
3,830
-2,360
-38% -$241K 0.19% 61
2013
Q4 		$700K Buy
6,190
+180
+3% +$16.2K 0.38% 26
2013
Q3 		$474K Buy
6,010
+15
+0.3% +$1.1K 0.29% 34
2013
Q2 		$395K Buy
+5,995
New +$386K 0.26% 42

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIM LLC's UTHR Position: Q1 2017 in Review

CIM LLC sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 3,546 shares — an estimated $509K sold.

CIM LLC first reported a position in UTHR in Q2 2013 and held it in 15 quarters. The position peaked at $700K in Q4 2013. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • CIM LLC reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
  • CIM LLC sold 3,546 United Therapeutics shares in Q1 2017, an estimated $509K.
  • CIM LLC first reported a position in United Therapeutics in Q2 2013 and held it in 15 quarters.
  • CIM LLC's United Therapeutics position peaked at $700K in Q4 2013.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on CIM LLC's 13F filing for Q1 2017, filed 18 Apr 2017.